Advanced search
Start date

Post-doctorate fellow in search of new drugs against Hypercholesterolemia, based on specific genetic and epigenetic markers of the Brazilian population

Grant number: 19/06172-4
Support Opportunities:Scholarships in Brazil - Post-Doctoral
Effective date (Start): May 01, 2019
Effective date (End): November 30, 2021
Field of knowledge:Health Sciences - Pharmacy
Principal Investigator:Fausto Feres
Grantee:Glaucio Monteiro Ferreira
Host Institution: Instituto Dante Pazzanese de Cardiologia (IDPC). Fundação Adib Jatene (FAJ). Secretaria da Saúde (São Paulo - Estado). São Paulo , SP, Brazil
Associated research grant:17/50342-6 - Institutional development plan in research (PDIp), AP.PDIP
Associated scholarship(s):19/24112-9 - Novel HMG-CoA reductase inhibitors development by integrating dyslipidemic patients' genetic studies and molecular modelling, BE.EP.PD


Statins are the most commonly prescribed medications in the world. However, although considered safe, they are associated with several adverse effects, mainly those related to Myalgia and Rhabdomyolysis and other muscular symptoms related to the use of statins (SMRE), about 65% of cases of low adherence. These characteristics of statins can impair primary and secondary prevention, which consequently leads to increased morbidity, hospitalizations and mortality due to cardiovascular diseases, burdening the Unified Health System (SUS). Pharmacogenetic studies associate the risk of SMRE with profile of DNA variants. Therewith, used genetic informations for development of new drugs using strategies in silico and in vitro. The purpose of this study is using genetic information from hyperlipidemic and SMRE patients to understand molecular interactions associated with the adverse effect and to develop new structures of HMG-CoA reductase inhibitors (HMGCR) with improved efficacy and safety. For this, the variants identified by high-throughput sequencing, in a study in progress at the Dante Pazzanese Institute, with potential alteration of functional effect, support the studies of molecular interaction by Computer-Aided Drug Design (CADD), for the construction of three-dimensional models between protein structures (with and without mutations). In silico studies performed to search for new potential ligands against HMGCR based on the constructed models. Thus, new drug planning studies follow two strategies to search for these possible new bioactive compounds: Ligand Based Drug Design (LBDD) and Structure Based Drug Design (SBDD). Such as, molecular docking, molecular force fields (MIF's), virtual screening, enzymatic kinetic tests of HMGCR inhibition and structural optimization. This studies, search to link Molecular Biology and Medicinal Chemistry in the constructed for new drugs with against Hypercholesterolemia, contributing to the increase of therapeutic adherence, with consequent reduction of the risks of cardiovascular events and direct costs to the public health. (AU)

News published in Agência FAPESP Newsletter about the scholarship:
Articles published in other media outlets (0 total):
More itemsLess items

Scientific publications
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
SOUZA, CAMILA O.; TEIXEIRA, ALEXANDRE A. S.; BIONDO, LUANA AMORIM; SILVEIRA, LOREANA SANCHES; DE SOUZA BREDA, CRISTIANE N.; BRAGA, TARCIO T.; CAMARA, NIELS O. S.; BELCHIOR, THIAGO; FESTUCCIA, WILLIAM T.; DINIZ, TIEGO A.; et al. Palmitoleic acid reduces high fat diet-induced liver inflammation by promoting PPAR-gamma-independent M2a polarization of myeloid cells. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, v. 1865, n. 10, . (13/04765-1, 19/06172-4, 19/24112-9, 15/19530-5, 16/01409-8)
DOS SANTOS, BENEDITO MATHEUS; FERREIRA, GLAUCIO MONTEIRO; TAVARES, MAURICIO TEMOTHEO; DE BONA, JULIO CESAR; HIRATA, MARIO HIROYUKI; DE PAULA, VANDERLUCIA FONSECA; SATURNINO, KLAUS CASARO; SOARES, ANDREIMAR MARTINS; MENDES, MIRIAN MACHADO. Antiophidic activity of the secondary metabolite lupeol isolated from Zanthoxylum monogynum. Toxicon, v. 193, p. 38-47, . (19/06172-4, 16/12899-6, 19/24112-9)
SILVA, JOAO VITOR; SAVINO, DEBORA; HIRATA, MARIO HIROYUKI; FERREIRA, GLAUCIO MONTEIRO; GIAROLLA, JEANINE. Zika Virus NS2B-NS3 Protease: Quantum Chemical Properties Insights into Designing Inhibitory Peptides. PROTEIN AND PEPTIDE LETTERS, v. 29, n. 11, p. 10-pg., . (19/06172-4)

Please report errors in scientific publications list by writing to: